login
login
Image header Agence Europe
Europe Daily Bulletin No. 12795
Contents Publication in full By article 19 / 28
EU RESPONSE TO COVID-19 / Health

European Commission signs a third group purchase contract for 220,000 doses of a potential Covid-19 treatment

The European Commission announced on Tuesday 21 September that it had signed a new group purchase contract for a candidate treatment against Covid-19.

The treatment in question - which is still undergoing a rolling review by the European Medicines Agency (EMA) - combines the antibodies bamlanivimab and etesevimab, and is being developed by the American pharmaceutical company Eli Lilly.

It was identified last June by the Commission as one of the five “most promising” treatment solutions...

Contents

ECONOMY - FINANCE - BUSINESS
EXTERNAL ACTION
SECTORAL POLICIES
SOCIAL - YOUHT
EU RESPONSE TO COVID-19
NEWS BRIEFS